Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Apr 27, 2026
4 Apr 10, 2026 4
144 Apr 9, 2026
ARS Apr 9, 2026 ARS
DEFA14A Apr 9, 2026 DEFA14A
DEF 14A Apr 9, 2026 DEF 14A
4 Apr 1, 2026 4
4 Apr 1, 2026 4
144 Mar 31, 2026
144 Mar 31, 2026
4 Mar 26, 2026 4
8-K Mar 26, 2026 8-K
144 Mar 24, 2026
4 Mar 17, 2026 4
4 Mar 13, 2026 4
4 Mar 13, 2026 4
4 Mar 13, 2026 4
144 Mar 12, 2026
144 Mar 12, 2026
144 Mar 12, 2026
8-K Mar 12, 2026 8-K
424B5 Mar 11, 2026 424B5
S-3MEF Mar 10, 2026 S-3MEF
424B5 Mar 9, 2026 424B5
S-8 Mar 9, 2026 S-8
← Newer Page 3 of 27 · 658 filings Older →